FDA Grants Orphan Drug Status To Two New Therapies In a Row, And These Two Groups Of Patients Are Expected To Benefit!
New Drug For IDH1 Mutation/Relapsed/Refractory Acute Myeloid Leukaemia With Good Complete Remission Rates And Manageable Toxicity
US National Children's Hospital
Innovative Therapy Zolbetuximab In Combination With Chemotherapy Significantly Improves Survival Of Gastric Cancer Patients!
For Fatal Rhabdomyosarcoma, New Atr Inhibitors May Hold Therapeutic Promise
What To Do If You Have Severe Itchy Hair Loss
